Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis
- PMID: 8333339
- DOI: 10.1007/978-1-4615-2920-0_38
Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis
Abstract
Although the mechanisms governing EC activation are not well understood, evidence points to a role for locally released cytokines from activated leukocytes. We propose that the sequence of events that result in EC activation are important in perivascular leukocyte infiltration into the CNS seen in MS. In the present study we examined expression of EC activation antigens on cerebral microvessels from patients with MS using immunofluorescence staining and quantitation by laser cytometry. Normal human microvessels do not express MHC class II antigens (Ags), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), or the urokinase plasminogen activator receptor (uPA-R). They express low levels of transferrin receptors and express factor VIII. Microvessels prepared from MS brain with plaque involvement expressed decreased factor VIII and increased transferrin receptors (tfR). Expression of the adhesion molecules VCAM-1, and ICAM-1 were found on 80% of isolated microvessels. HLA-DR Ags were expressed on 40-60% of microvessels, and the uPA-R was expressed on 50% of MS microvessels examined. MHC class II Ags co-express with VCAM-1 and ICAM-1 more frequently than with the uPA-R. Results indicate that activation of EC in MS is likely to be an important factor in disease pathology.
Similar articles
-
Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis.Ann Neurol. 1994 Jan;35(1):89-97. doi: 10.1002/ana.410350114. Ann Neurol. 1994. PMID: 7506877
-
Cytokine-mediated activation of cultured CNS microvessels: a system for examining antigenic modulation of CNS endothelial cells, and evidence for long-term expression of the adhesion protein E-selectin.J Cereb Blood Flow Metab. 1994 Sep;14(5):837-44. doi: 10.1038/jcbfm.1994.105. J Cereb Blood Flow Metab. 1994. PMID: 7520453
-
Transforming growth factor beta 1 inhibits cytokine-induced CNS endothelial cell activation.Mol Chem Neuropathol. 1994 Aug;22(3):161-75. doi: 10.1007/BF03160103. Mol Chem Neuropathol. 1994. PMID: 7993525
-
Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation.J Neurosci Res. 1996 May 1;44(3):223-34. doi: 10.1002/(SICI)1097-4547(19960501)44:3<223::AID-JNR3>3.0.CO;2-I. J Neurosci Res. 1996. PMID: 8723761
-
Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.Lupus. 2003;12(7):539-45. doi: 10.1191/961203303lu398oa. Lupus. 2003. PMID: 12892395 Review.
Cited by
-
The pathology of multiple sclerosis and its evolution.Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1635-40. doi: 10.1098/rstb.1999.0508. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603616 Free PMC article. Review.
-
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis.J Neurol. 2005 May;252(5):526-33. doi: 10.1007/s00415-005-0681-7. J Neurol. 2005. PMID: 15895275 Clinical Trial.
-
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.PLoS One. 2012;7(12):e52208. doi: 10.1371/journal.pone.0052208. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284936 Free PMC article.
-
Preserving and enhancing mitochondrial function after stroke to protect and repair the neurovascular unit: novel opportunities for nanoparticle-based drug delivery.Front Cell Neurosci. 2023 Jul 7;17:1226630. doi: 10.3389/fncel.2023.1226630. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37484823 Free PMC article. Review.
-
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.EJNMMI Res. 2020 Jul 28;10(1):87. doi: 10.1186/s13550-020-00673-7. EJNMMI Res. 2020. PMID: 32725278 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous